Loading...
Activity of 2-Aryl-2-(3-indolyl)acetohydroxamates Against Drug-Resistant Cancer Cells
Aksenov, Alexander V. Smirnov, Alexander N. Magedov, Igor V. Reisenauer, Mary R. Aksenov, Nicolai A. Aksenova, Inna V. Pendleton, Alexander L. Nguyen, Gina Johnston, Robert K. Rubin, Michael
Aksenov, Alexander V.
Smirnov, Alexander N.
Magedov, Igor V.
Reisenauer, Mary R.
Aksenov, Nicolai A.
Aksenova, Inna V.
Pendleton, Alexander L.
Nguyen, Gina
Johnston, Robert K.
Rubin, Michael
Citations
Altmetric:
Abstract
Many types of tumor, including glioma, melanoma, non-small cell lung, esophageal, head and neck cancer, among others, are intrinsically resistant to apoptosis induction and poorly responsive to current therapies with proapoptotic agents. In addition, tumors often develop multi-drug resistance based on the cellular efflux of chemotherapeutic agents. Thus, novel anticancer agents capable of overcoming these intrinsic or developed tumor resistance mechanisms are urgently needed. We describe a series of 2-aryl-2-(3-indolyl)acetohydroxamic acids, which are active against apoptosis- and multidrug-resistant cancer cells as well as glioblastoma neurosphere stem-like cell cultures derived from patients. Thus, the described compounds serve as a novel chemical scaffold for the development of potentially highly effective clinical cancer drugs.
Description
Date
2015-03-12
Journal Title
Journal ISSN
Volume Title
Publisher
American Chemical Society
Collections
Research Projects
Organizational Units
Journal Issue
Keywords
Citation
Aksenov, A. V., Smirnov, A. N., Magedov, I. V., Reisenauer, M. R., Aksenov, N. A., Aksenova, I. V., … Frolova, L. V. (2015). Activity of 2-Aryl-2-(3-indolyl)acetohydroxamates Against Drug-Resistant Cancer Cells. Journal of Medicinal Chemistry, 58(5), 2206–2220. http://doi.org/10.1021/jm501518y